XNCR Xencor, Inc.
$24.41▲ +0.62%
Healthcare
Other
After hours
$24.78▲ +1.52%
Sep 11, 7:30 PM ET
Volume 905.3K
Avg Volume (10D) 1.39M
Key Metrics & Fundamentals
Market Cap
$1.81B
P/E Ratio
–
Div Yield
–%
52W Range
8.26 - 30.61
% vs 50 MA
11.97%
% vs 200 MA
59.34%
RSI-14
48.3
MACD Histogram
-0.7200
Beta (1Y vs SPY)
1.23
Free Cash Flow
-$56.20M
Gross Rev
$51.22M
Gross Profit
$51.22M
EBITDA
-$29.39M
COGS
–
Operating Exp
$88.29M
Operating Income
-$37.07M
EBIT
-$37.07M
Pretax Income
-$21.92M
Net Income
-$21.73M
EPS (Diluted)
-0.29
Price & Volume History
Loading chart…
Recent News
Ulcerative Colitis Market Outlook: 5 Late-Stage Drug Candidates to Watch | DelveInsight
GlobeNewswire · Sep 7, 2026 5:00 PM
Xencor to Present at the 2026 Cantor Global Healthcare Conference
Business Wire · Sep 2, 2026 8:01 PM
Raymond James Adjusts Xencor Price Target to $46 From $40, Maintains Strong Buy Rating
MT Newswires · Sep 1, 2026 11:49 AM
How Investors May Respond To Xencor (XNCR) Narrowing Quarterly Losses Amid Deeper First‑Half Deficit
Simply Wall St. · Aug 8, 2026 12:12 PM
Wedbush Adjusts Price Target on Xencor to $30 From $26, Maintains Outperform Rating
MT Newswires · Aug 6, 2026 12:47 PM
RBC Capital Adjusts PT on Xencor to $20 From $19, Maintains Outperform Speculative Risk Rating
MT Newswires · Aug 6, 2026 12:01 PM
Xencor (XNCR) Reports Q2 Loss, Beats Revenue Estimates
Zacks · Aug 5, 2026 9:25 PM
Xencor: Q2 Earnings Snapshot
Associated Press · Aug 5, 2026 8:19 PM
Xencor Reports Second Quarter 2026 Financial Results
Business Wire · Aug 5, 2026 8:01 PM
Sector Update: Healthcare Stocks Decline Late Afternoon
MT Newswires · Jul 30, 2026 7:46 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See XNCR's money flow as a full page
Social Sentiment
No Reddit posts found for XNCR.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.